Company intelligence / Profile preview

Eu Yan Sang

Singapore, Singaporeeuyansang.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Over its history of more than a century, Eu Yan Sang has grown from a single shop providing herbal remedies to tin miners into one of Asia’s largest traditional Chinese medicine brands. It operates over 170–300 retail outlets and nearly 40 clinics across Singapore, Malaysia, Hong Kong, Macau and Australia. The company offers more than 300 proprietary products as well as over a thousand types of herbs. Clinical results in the Western sense are not typically published due to the nature of TCM products. In recent years it has modernized its product lines with capsules and ready-to-consume formats while maintaining strict quality control standards. In April–June 2024 it was acquired by Mitsui & Co. and Rohto Pharmaceutical for S$800 million (~US$594 million). The company also runs integrative clinics offering acupuncture and other therapies.

Therapeutic areas
EndocrinologyImmunologyOtherPsychiatryCardiovascular
Modalities
Herbal medicineNatural health supplementsTraditional Chinese Medicine formulationsSmall molecule (for herbal extracts and supplements)Non-pharmacological therapy (acupuncture and TCM physical therapies)
Industry
Non-Academic Healthcare
02

Drug pipeline

2 assets

Pure Cordyceps

Commercial
Indications
Immunity, Energy

1 more asset in the full pipeline.

Request access →
03

Partnerships

Nestlé partnership for herbal soup product line

Beyond the preview

Go deeper on Eu Yan Sang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eu Yan Sang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call